biliary cystadenoma
Recently Published Documents


TOTAL DOCUMENTS

187
(FIVE YEARS 24)

H-INDEX

23
(FIVE YEARS 1)

2021 ◽  
Vol 8 ◽  
Author(s):  
Yan Tang ◽  
Chenyu Wang ◽  
Shunjun Fu ◽  
Ting Li ◽  
Guolin He

Background: Biliary cystadenomas are rare cystic tumors of the bile duct system that are mostly benign but also have the possibility of malignant transformation. Biliary cystadenomas mostly occur in the intrahepatic bile ducts and are more common in middle-aged women. Due to non-specific radiology, preoperative diagnosis is difficult and is usually performed by postoperative pathology. Complete resection is the best treatment option, and the postoperative prognosis is good.Case Description: This study reports a case of a patient with biliary cystadenoma who was diagnosed with simultaneous chronic hepatitis B and colon (hepatic flexure) adenomatous polyps. The patient presented to the doctor because of abdominal pain, and a blood test showed hepatitis B. Computed tomography revealed both right liver and colonic lesions. Colonoscopy revealed polyps, and the postoperative pathological diagnosis was adenomatous polyps. Laparoscopic resection of the right liver tumor was performed, and it was diagnosed as hepatobiliary cystadenoma by postoperative pathological analysis combined with immunohistochemistry.Conclusion: In patients with chronic hepatitis, the shape of biliary cystadenoma may not be very typical, and it is necessary to combine this with immunohistochemistry for diagnosis. When multiple lesions are detected in the painful area, the diagnosis of each lesion and its treatment sequence are worthy of consideration. Under normal circumstances, the prognosis of biliary cystadenoma is good; however, in patients with chronic hepatitis B, more cases need to be observed for verification.


2021 ◽  
Vol 14 (12) ◽  
pp. e246392
Author(s):  
Preethi Raja Navaneethan ◽  
Anuja Abraham ◽  
Kavitha Abraham ◽  
Aparna Jagannathan

The aetiological diagnosis of cystic masses detected on routine ultrasound during pregnancy can be challenging. Unless approached cautiously with a detailed history and adequate use of imaging techniques, misdiagnosis of these cystic masses are not uncommon. Cystic masses diagnosed during pregnancy are mostly of ovarian origin; however, other non-ovarian cystic masses are also detected incidentally or at laparotomy/laparoscopy. We report a rare case of ruptured biliary cystadenoma in a pregnant woman diagnosed at emergency laparotomy. She was taken up for surgery with a provisional impression of ruptured adnexal cyst. However, the cyst was found to be arising from the liver and the histology of the cyst wall was reported as biliary cystadenoma.


2021 ◽  
pp. 000313482110540
Author(s):  
Aman Kumar ◽  
Alex Zendel ◽  
Michael Batres ◽  
David A. Gerber ◽  
Chirag S. Desai

Background and Aims Simple liver cyst (SHC) is a benign condition with no malignant potential. They are typically discovered incidentally due to the increased use of abdominal imaging, but some patients may present with abdominal pain. A radiologist’s differential diagnosis in cases of SHC will often include “rule out biliary cystadenoma.” Under these circumstances, patients and surgeons are more likely to pursue surgical options even in asymptomatic cases. The aim of this study is to conduct a retrospective analysis of presentation, radiologic reporting, management plan, and histopathology of patients referred to a tertiary hospital in order to determine the correlation between radiology and histology. Methods We retrospectively analyzed the clinical, radiological, and histopathological data of 20 patients operated for a diagnosis of a cystic lesion in the liver. Result The CT/MRI of 6 (30%) patients was reported as a biliary cystadenoma, 13 (65%) were reported as a simple hepatic cyst and 1 patient (5%) had hepatocellular carcinoma (HCC) with the additional diagnosis of multiple hepatic cysts. The lesion reported as HCC on the scan was separate from the cystic lesions. The modality of imaging for these cysts was evenly split, 50% of patients had a CT scan, and 50% had an MRI performed. All imaging studies were interpreted by an attending radiologist and most of them were discussed in multidisciplinary meetings. Nineteen patients (95%) had an intraoperative diagnosis of a simple liver cyst based on its visual appearance and clear fluid within the cyst. These patients underwent cyst wall fenestration and de-roofing with the cyst wall sent for histopathology. One patient (5%) with HCC underwent a non-anatomical liver resection. Histopathology was conclusive for a benign hepatic cystic lesion from the cyst wall biopsy. All 20 patients in this study underwent surgery, either due to symptoms or due to radiologic diagnosis of BCA. Four of the 20 cases (20%) were asymptomatic and out of these four cases, 3 (75%) were diagnosed as cystadenoma on the preoperative imaging studies. All 19 cases were diagnosed as a simple liver cyst on pathology. Conclusion In summary, there is a growing trend of “ruling-out the diagnosis of biliary cystadenoma” in patients who present with liver cysts. Patients are appropriately more anxious after this preoperative diagnosis and the treating surgeons have medico-legal concerns regarding conservative management in asymptomatic patients diagnosed as BCA. This single center experience draws attention to the radiology criteria utilized for diagnosing a biliary cystadenoma and suggests that it is time to revisit the imaging interpretation and differential diagnosis.


2021 ◽  
pp. 12-13
Author(s):  
Moka .Rajesh ◽  
Shaik Nazia ◽  
Angani. Sri Radha Krishna Varma

Hepatobiliary cystadenocarcinoma is a very rare cystic tumor that arises in the liver or, less frequently, in the extrahepatic biliary system mostly seen in elderly patients. It has been shown to arise in congenital liver cysts, bile ducts, biliary cystadenoma, in the context of bro- polycystic disease and in the hepatoduodenal ligament. In the present case report, we describe a case of rare entity of hepatobiliary cystadenocarcinoma presented in a 36 year old male patient presented to opd with complaints of pain abdomen in right side of upper abdomen since 2 months. Main concern of this case report is preoperative imaging is imprecise and frequently misdiagnosed as benign cystic lesions and delays in treatment.


2021 ◽  
Vol 116 (1) ◽  
pp. S1427-S1428
Author(s):  
Sara Samad ◽  
Pawel Szurnicki ◽  
Gregory Wagner ◽  
Christopher Chum

Author(s):  
Arkadeep Dhali ◽  
Sukanta Ray ◽  
Gopal Krishna Dhali ◽  
Sujan Khamrui ◽  
Ranajoy Ghosh

Extrahepatic Mucinous Biliary Cystadenoma is an extremely rare clinical entity which can present with varieties of vague clinical signs and symptoms. Gastric outlet obstruction caused due to this has never been reported before. We highlighted the diagnostic dilemma we faced, when radiological investigations couldnot suggest the accurate organ of origin.


2021 ◽  
Vol 9 (26) ◽  
pp. 7886-7892
Author(s):  
Chen-Hao Che ◽  
Zhen-Hua Zhao ◽  
Hui-Ming Song ◽  
Yuan-Yuan Zheng

2021 ◽  
Vol 11 ◽  
Author(s):  
Yongguang Yang ◽  
Weiheng Mai ◽  
Weifeng Chen ◽  
Chao Yang ◽  
Mingyi Li ◽  
...  

Apatinib is a new oral tyrosine kinase inhibitor that targets vascular endothelial growth factor receptor-2. It has been proven effective in treating multiple solid tumors. Herein, we report the case of a 67-year-old Chinese patient who was diagnosed with recurrent and malignant transformation of intrahepatic biliary cystadenoma. After multidisciplinary team discussion, the team considered that the remaining liver volume was insufficient for surgical resection. The patient refused chemotherapy and radiotherapy and was willing to take apatinib. Initially, the patient experienced severe tongue ulcers and difficulty eating. The dose of apatinib was then adjusted to 250 mg/day. To date, he has been taking apatinib for 48 months. Regular re-examination showed that the tumor had significantly decreased in size. On January 16, 2021, a CT scan revealed a tumor diameter of 4.5 cm. In our case, the patient achieved partial response and progression-free survival(PFS) of 48.0 months. During treatment, the patient’s appetite and mental state were expected. The treatment did not induce hypertension, fatigue, hand-foot syndrome, or liver and kidney damage. Apatinib may be an option for the treatment of advanced intrahepatic biliary cystadenocarcinoma. Its toxicity is controllable and tolerable. The exact curative effect still needs to be evaluated in more cases.


2021 ◽  
Vol 8 (5) ◽  
pp. e00596
Author(s):  
Daniel Stenberg ◽  
Mohammed Alkhero ◽  
Mazen M. Jamal ◽  
Michael Tran
Keyword(s):  

2021 ◽  
Vol 8 (5) ◽  
pp. 1621
Author(s):  
Amarjeet E. Tandur ◽  
Solaimuthu Rajagopal ◽  
Rahul K. Mishra ◽  
Ajay H. Bhandarwar ◽  
Guru Baradwaj ◽  
...  

Biliary cystadenoma (BCA) is a rare cystic neoplasm of liver with malignant potential and female predominance, mostly asymptomatic that will lead to late identification. BCAs are mostly do not communicate with Biliary tract but communication was reported in some studies, BCA has higher rate of recurrence after incomplete removal so the standard management is complete resection or partial hepatectomy. We report a case of BCA in 72-year aged female with ECOG score 3. Computed tomography showed BCA involving segment II, III, IV and VIII of liver without any malignant features, which was treated with laparoscopic deroofing with omentopexy and no recurrence at 1 year follow up. We used indocyanine green-fluorescent image to look for biliary communication. This study aims to report that minimal accesses surgery with deroofing and omentopexy can be alternative treatment for BCA without any malignant features in a poor performance status and use of Indocyanine green-fluorescent image to avoid biliary injury and rule out communication.


Sign in / Sign up

Export Citation Format

Share Document